XYH-21612-61955 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Dose 1 — Pfizer-BioNTech
2021-01-07
Registered in v-safe
2021-01-07
Dose 2 — Pfizer-BioNTech
2021-01-07
Survey response — day 0, dose 2
MedDRA: Bradycardia, Dizziness — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea

Free text: Bradycardia, lightheadedness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-08
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2021-01-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-14
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-01-14
Report sent to call center — day 7, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-21
Survey response — day 14, dose 2
MedDRA: Depression — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Sudden, abrupt worsening depression after 2nd vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-21
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-01-30
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-08
Call 1 — Left Voicemail
2021-08-31
Dose 3 — Pfizer-BioNTech
2022-11-30
Call 1 — Left Voicemail
2022-11-30
Call 1 — Left Voicemail
2022-11-30
Call 2 — Left Voicemail
2022-11-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-07	Pfizer-BioNTech
3	2021-08-31	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-08	Unsuccessful
2021-01-09	Unsuccessful
2021-01-14	Unsuccessful
2021-01-21	Unsuccessful

Free text

Release 1 — day 0, dose 2

2021-01-07

Systemic reaction (other): Bradycardia, lightheadedness

Release 2 — day 14, dose 2

2021-01-21

Symptoms: Sudden, abrupt worsening depression after 2nd vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Depression	✓	✓	✓
SRO	Bradycardia	✓	✓	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release